Safety and Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution

Clinical trial NCT04177082 · COMPLETED

Trial details

NCT number: NCT04177082
Sponsor: Cornea Associates of Texas
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Keratoconus Pellucid Marginal Corneal Degeneration Corneal Degeneration Corneal Ectasia

Start date: 2020-01-10
Primary completion: 2022-05-05
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.